Vicki Coutinho joined GammaDelta Therapeutics in 2019 and has 20 years’ experience from the pharmaceutical and biotech industry. Previously, Vicki headed the Regulatory Affairs department at Autolus Ltd. where she was responsible for the regulatory strategy and regulatory authorisations for several advanced CAR T-cell products. Vicki was instrumental in bringing multiple advanced CAR T-cell products for haematological malignancies to the clinic. Prior to Autolus, Vicki held Regulatory Affairs roles for almost 10 years within Contract Research Organisations, responsible for regulatory applications, product lifecycle management (Phase I-IV), quality and consultancy for over 200 medicinal products and medical devices. Vicki previously supervised the cGMP manufacture of autologous fibroblast cells and process optimisation for FDA submissions, that led to the Biologics License Application (BLA) for azficel-T at Fibrocell Science Inc. (formerly Isolagen Inc.).
Vicki received a degree in Physiology and Pharmacology from University College London, UK and a PhD in Neuroscience from the University of Bristol, UK.